Publications by authors named "Chenglan Yan"

Claim this Profile
E
Epidemiology, clinical features, antifungal resistance, and prognosis of fungemia in pediatric patients.
Chunyun Fu, Huan Zhang, Lishai Mo, Shuangjie Wang, Minxue Liu, Chenglan Yan

J Infect Dev Ctries· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between triglyceride glucose index and organ involvement in patients with systemic sclerosis.
Huidan Yang, Hao Cheng, Huifang Yang, Xiaoying Zhang, Lili Shang, Chenglan Yan, Hongyan Wen

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human bocavirus-1 infection in hospitalized pediatric patients with acute respiratory tract infections.
Jie Tan, Ziyin Huang, Wenting Tang, Guangbing Liu, Peiqun Li, Chenglan Yan

Microbiol Spectr· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and risk factors of Klebsiella pneumoniae infection in premature infants: a retrospective cohort study.
Xiaofen Wei, Jiahui Liang, Huan Zhang, Chenglan Yan, Xiangjun Lu, Yan Chen

BMC Infect Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute decrease in regulatory T cells and low-dose interleukin-2 therapy: restoring and expanding regulatory T cells to treat systemic sclerosis: a 24-week study.
Zhen Yu, Hao Cheng, Tingting Ding, Yuying Liang, Chenglan Yan, Hongyan Wen

Clin Exp Dermatol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Efficacy and Low Adverse Events of Methylprednisolone Pulses Combined to Low-Dose Glucocorticoids for Systemic Sclerosis: A Retrospective Clinical Study of 10 Years' Follow-Up.
Hao Cheng, Zhen Yu, Cheng-Lan Yan, Hui-Dan Yang, Chong Gao, Hong-Yan Wen

J Inflamm Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of belimumab/low-dose cyclophosphamide therapy in moderate-to-severe systemic lupus erythematosus.
Hao Cheng, Xiao-Ying Zhang, Hui-Dan Yang, Zhen Yu, Cheng-Lan Yan, Hong-Yan Wen

Front Immunol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased Absolute Number of Circulating Regulatory T Cells in Patients With Takayasu's Arteritis.
Wen Jia, Zi-Li Fu, Xia Wang, Jing Luo, Cheng-Lan Yan, Yan-Liu

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Belimumab for refractory systemic lupus erythematosus (SLE) involving the central nervous system.
Hao Cheng, Chen-Sheng Zhao, Cheng-Lan Yan, Chong Gao, Hong-Yan Wen

Eur J Intern Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased Serum 25-(OH)-D Level Associated With Muscle Enzyme and Myositis Specific Autoantibodies in Patients With Idiopathic Inflammatory Myopathy.
Zhen Yu, Hao Cheng, Yuying Liang, Tingting Ding, Chenglan Yan, Hongyan Wen

Front Immunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased numbers and sex-based differences of circulating regulatory T cells in patients with seropositive undifferentiated arthritis.
Hong-Qing Niu, Chenrui Yuan, Chenglan Yan, Na Li, Yuan-Sheng Lei

Ther Adv Chronic Dis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vincristine-cyclophosphamide combination therapy positively affects T-cell subset distribution in systemic lupus erythematosus patients.
Junwei Chen, Lijuan Ding, Wu Meng, Jinhua Yang, Chenglan Yan

Med Sci Monit· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis